Features
Get A Demo
Plans
Sign Up
Login
All Federal Contract IDV Awards
Help
Indefinite Delivery Contract SPE2DP16D0009
Award Date
9/13/16
Last Date to Order
9/12/17
Overview
🤔 AI Insights
Buyer Personas
Industry Personas
Buyer Personas In this Market
20
Activity
Contract IDVs
Contract Awards
46
Transactions
Price Lists
Opportunity Stack
3
Federal Agency
Medical Supply Chain
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
SPE2DP16D0009
Indefinite Delivery Contract
46
Federal Contract Awards
Description
4610028930 ! ZANAMIVIR FOR INHAL
Posted 9/13/16, 12:00 AM
Name
Description
Awardee
Potential Value
(Click to sort descending)
Award Date
(Click to sort descending)
Completion Date
(Click to sort descending)
Updated At
(Click to sort descending)
Delivery Order SPE2DP16D0009-0132
8503654418 ! ZANAMIVIR FOR INHAL
Glaxosmithkline, LLC
$23.2k
9/16/16
12/15/16
9/16/16
Delivery Order SPE2DP16D0009-0017
8503643937 ! ZANAMIVIR FOR INHAL
Glaxosmithkline, LLC
$17.4k
9/14/16
12/13/16
9/14/16
Delivery Order SPE2DP16D0009-0051
8503647821 ! ZANAMIVIR FOR INHAL
Glaxosmithkline, LLC
$16.2k
9/15/16
12/14/16
9/15/16
Delivery Order SPE2DP16D0009-0133
8503654503 ! ZANAMIVIR FOR INHAL
Glaxosmithkline, LLC
$22.5k
9/16/16
12/15/16
9/16/16
Delivery Order SPE2DP16D0009-0080
8503652085 ! ZANAMIVIR FOR INHAL
Glaxosmithkline, LLC
$20.0k
9/16/16
12/15/16
9/16/16
Name
Description
Solicitation Number
Federal Agency
Type
Posted Date
(Click to sort descending)
J&A302-1SPE2DP16D0009
This is a Justification and Approval (J&A) for Relenza SPE2DP-16-D-0009, which is being posted as required by FAR 6.305. The J&A is attached to this notice. Awarded contract SPE2DP-16-D-0009 to unknown vendor for unknown amount on 2016-09-13.
SPE2DP-16-R-0005
Defense Logistics Agency Land and Maritime
Limited / Sole Source Justification 3/3
9/16/16, 7:01 AM
Relenza/Zanamivir
Awarded contract SPE2DP-16-D-0009 to GlaxoSmithKline for 6,948,000.00 on 2016-09-13.
SPE2DP-16-R-0005
Defense Logistics Agency Land and Maritime
Award Notice 2/3
9/13/16, 8:05 AM
Zanamivir for Inhalation
Added: Mar 29, 2016 2:45 pm The Defense Logistics Agency Troop Support is soliciting proposals for the supply of Zanamivir for Inhalation. A Firm Fixed Price Requirements contract is proposed with a one-year Base Period. All DoD requirements will be placed on the proposed contract. The estimated quantity for the Base Period is 400,000 bottles.Delivery is to be FOB Destination and delivered within 90 days from date of the delivery order. Contractor is required to deliver to various Contiguous United States (CONUS) locations provided at the time of the delivery order. All responsible sources may submit a proposal and shall be considered by the Agency. The successful contractor shall have Food and Drug Administration (FDA) approval to sell Zanamivir for Inhalation before award of the contract. Solicitation SPE2DP-16-R-0005 is expected to be issued on or around April 15, 2016 and can be found on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. The point of contact is Mat Wilson, DLA Troop Support-FSAC, 215-737-5654.The Solicitation will be issued under authority 10 U.S.C. 2034 (c) 1, only one responsible source.
SPE2DP-16-R-0005
Defense Logistics Agency Troop Support Medical
Award Notice 1/3
3/29/16, 2:45 PM